Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 1997

View Archived Issues

Chemoprotective properties of lisofylline reported

Clinical progress for Kirin's calcimimetic compound reported

Patient enrollment completed for ARDS phase Ib trial

PAF antagonist demonstrates antipruritic activity in patients with atopic dermatitis

Plant-based estrogen prevents osteoporosis safely and effectively

More on protein farnesyltransferase inhibitors from Merck & Co.

U. of Florida prepares new metal chelators

Antidiabetic agents under development at Takeda

Boehringer Mannheim describes antiplatelet agents

Several series of integrin antagonists prepared at Searle

Potent, broad-spectrum carbapenem discovered at Fujisawa

Promising results reported from rhATIII trial

Parke-Davis identifies selective FGF receptor tyrosine kinase inhibitor

Verapamil derivative from Toa Eiyo with potential in supraventricular tachycardia

FDA approves Nutropin for GH deficiency in adults

Pentose receives U.S. and European patent allowances for Papirine compounds

Genzyme General seeks U.S. and European approval for Thyrogen

Naratriptan acts through 5-HT1B/1D receptors and accesses the CNS

Daiichi's Floxin receives FDA approval

Italian launch for Alzheimer's disease treatment

First biologic approved for treatment of diabetic foot ulcers

Behavioral effects of novel mGluR agonist in rats

AEterna's psoriasis agent moves to phase I/II in Canada

Animal study indicates potential of GAT inhibitors for anxiety

Hyal discontinues development of osteoarthritis drug

FDA issues health advisory for anticoagulants

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...